Department of Cardiology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Research Center for Metabolic and Cardiovascular Diseases, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Clin Sci (Lond). 2022 Jun 30;136(12):989-1003. doi: 10.1042/CS20220236.
Activation of the angiotensin II type 2 receptor (AT2R) induces diuresis and natriuresis. Increased expression or/and activity of G-protein-coupled receptor kinase 4 (GRK4) or genetic variants (e.g., GRK4γ142V) cause sodium retention and hypertension. Whether GRK4 plays a role in the regulation of AT2R in the kidney remains unknown. In the present study, we found that spontaneously hypertensive rats (SHRs) had increased AT2R phosphorylation and impaired AT2R-mediated diuretic and natriuretic effects, as compared with normotensive Wistar-Kyoto (WKY) rats. The regulation by GRK4 of renal AT2R phosphorylation and function was studied in human (h) GRK4γ transgenic mice. hGRK4γ142V transgenic mice had increased renal AT2R phosphorylation and impaired AT2R-mediated natriuresis, relative to hGRK4γ wild-type (WT) littermates. These were confirmed in vitro; AT2R phosphorylation was increased and AT2R-mediated inhibition of Na+-K+-ATPase activity was decreased in hGRK4γ142V, relative to hGRK4γ WT-transfected renal proximal tubule (RPT) cells. There was a direct physical interaction between renal GRK4 and AT2R that was increased in SHRs, relative to WKY rats. Ultrasound-targeted microbubble destruction of renal GRK4 decreased the renal AT2R phosphorylation and restored the impaired AT2R-mediated diuresis and natriuresis in SHRs. In vitro studies showed that GRK4 siRNA reduced AT2R phosphorylation and reversed the impaired AT2R-mediated inhibition of Na+-K+-ATPase activity in SHR RPT cells. Our present study shows that GRK4, at least in part, impairs renal AT2R-mediated diuresis and natriuresis by increasing its phosphorylation; inhibition of GRK4 expression and/or activity may be a potential strategy to improve the renal function of AT2R.
血管紧张素 II 型受体(AT2R)的激活可引起利尿和利钠作用。G 蛋白偶联受体激酶 4(GRK4)的表达增加或/和活性增加(例如,GRK4γ142V)可导致钠潴留和高血压。GRK4 是否在肾脏中调节 AT2R 尚不清楚。在本研究中,我们发现与正常血压的 Wistar-Kyoto(WKY)大鼠相比,自发性高血压大鼠(SHR)的 AT2R 磷酸化增加,并且 AT2R 介导的利尿和利钠作用受损。在人(h)GRK4γ 转基因小鼠中研究了 GRK4 对肾脏 AT2R 磷酸化和功能的调节。hGRK4γ142V 转基因小鼠的肾脏 AT2R 磷酸化增加,AT2R 介导的利钠作用受损,与 hGRK4γ 野生型(WT)同窝仔相比。这些在体外得到了证实;与 hGRK4γ WT 转染的肾近端小管(RPT)细胞相比,AT2R 磷酸化增加,AT2R 介导的 Na+-K+-ATP 酶活性抑制作用降低。与 WKY 大鼠相比,SHR 中肾脏 GRK4 与 AT2R 之间存在直接的物理相互作用,这种相互作用增加了。超声靶向微泡破坏肾脏 GRK4 可降低肾脏 AT2R 磷酸化,并恢复 SHR 受损的 AT2R 介导的利尿和利钠作用。体外研究表明,GRK4 siRNA 降低了 AT2R 磷酸化,并逆转了 SHR RPT 细胞中受损的 AT2R 介导的 Na+-K+-ATP 酶活性抑制作用。本研究表明,GRK4 至少部分通过增加其磷酸化来损害肾脏 AT2R 介导的利尿和利钠作用;抑制 GRK4 的表达和/或活性可能是改善 AT2R 肾功能的一种潜在策略。